Shrinking myocardial infarction size, lowering serum and myocardial CK and AST activities, enhancing myocardial CAT, SOD, and GSH-Px levels, while diminishing MDA content, inhibiting iNOS but activating cNOS and heightening NO content. The gene discussed is NOS2; the disease is myocardial infarction.